Role of microRNAs in drug-resistant ovarian cancer cells
Top Cited Papers
- 31 December 2008
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 111 (3), 478-486
- https://doi.org/10.1016/j.ygyno.2008.08.017
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationshipCancer Treatment Reviews, 2007
- Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?Current Cancer Drug Targets, 2007
- Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear functionInternational Journal of Cancer, 2007
- Six1 Overexpression in Ovarian Carcinoma Causes Resistance to TRAIL-Mediated Apoptosis and Is Associated with Poor SurvivalCancer Research, 2007
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agentsBiochemical Pharmacology, 2006
- Signal Transducers and Activators of Transcription 3 Pathway Activation in Drug-Resistant Ovarian CancerClinical Cancer Research, 2006
- Expression of Basic Fibroblast Growth Factor Correlates with Resistance to Paclitaxel in Human Patient TumorsPharmaceutical Research, 2006
- Biological characterization of ovarian cancer: prognostic and therapeutic implicationsAnnals Of Oncology, 2005
- Role of chemotherapy in the management of epithelial ovarian cancerExpert Review of Anticancer Therapy, 2005